Skip to Content

Comvax

In the US, Comvax (haemophilus b conjugate (prp-omp) vaccine/hepatitis b pediatric vaccine systemic) is a member of the drug class vaccine combinations and is used to treat Haemophilus influenzae Prophylaxis and Hepatitis B Prevention.

US matches:

Ingredient matches for Comvax

Haemophilus Type b Conjugate Vaccine

Haemophilus Type b Conjugate Vaccine is reported as an ingredient of Comvax in the following countries:

  • United States

Hepatitis B Vaccine, rDNA

Hepatitis B Vaccine, rDNA is reported as an ingredient of Comvax in the following countries:

  • United States

International Drug Name Search

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide